Genetic Polymorphisms of CYP3A5, CHRM2, and ZNF498 and Their Association With Epilepsy Susceptibility: A Pharmacogenetic and Case–control Study

Pharmacogenomics and Personalized Medicine - New Zealand
doi 10.2147/pgpm.s212433

Related search